{"id":"https://openalex.org/W3083312408","doi":"https://doi.org/10.1158/1538-7445.am2020-ct214","title":"Abstract CT214: CANOPY-1: Safety run-in results from phase (ph) 3 study of canakinumab (CAN) or placebo (PBO) in combination (comb) with pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC","display_name":"Abstract CT214: CANOPY-1: Safety run-in results from phase (ph) 3 study of canakinumab (CAN) or placebo (PBO) in combination (comb) with pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083312408","doi":"https://doi.org/10.1158/1538-7445.am2020-ct214","mag":"3083312408"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-ct214","doi":"https://doi.org/10.1158/1538-7445.am2020-ct214","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-ct214","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053521833","display_name":"Bruce Evan Johnson","orcid":"https://orcid.org/0000-0002-5252-3677","observed_orcids":["https://orcid.org/0000-0002-5252-3677"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce E. Johnson","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100719069","display_name":"Tae Min Kim","orcid":"https://orcid.org/0000-0001-6145-4426","observed_orcids":["https://orcid.org/0000-0001-6145-4426"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Tae Min Kim","raw_affiliation_strings":["2Seoul National University Hospital, Seoul, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Seoul National University Hospital, Seoul, Republic of Korea;","institution_ids":["https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078862785","display_name":"T. Jeroen N. Hiltermann","orcid":"https://orcid.org/0000-0002-0665-2160","observed_orcids":["https://orcid.org/0000-0002-0665-2160"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"T. Jeroen N. Hiltermann","raw_affiliation_strings":["3University Medical Center Groningen, Groningen, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University Medical Center Groningen, Groningen, Netherlands;","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087836238","display_name":"Fabrice Barl\u00e9si","orcid":"https://orcid.org/0000-0001-5793-3539","observed_orcids":["https://orcid.org/0000-0001-5793-3539"]},"institutions":[{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabrice Barlesi","raw_affiliation_strings":["4Aix-Marseille University, Marseille, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Aix-Marseille University, Marseille, France;","institution_ids":["https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114929422","display_name":"Christian Groh\u00e9","orcid":"https://orcid.org/0000-0003-2724-7647","observed_orcids":["https://orcid.org/0000-0003-2724-7647"]},"institutions":[{"id":"https://openalex.org/I4210150902","display_name":"Evangelische Lungenklinik Berlin","ror":"https://ror.org/05q4r1796","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210145344","https://openalex.org/I4210150902"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Grohe","raw_affiliation_strings":["5Evangelische Lungenklinik Berlin, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Evangelische Lungenklinik Berlin, Berlin, Germany;","institution_ids":["https://openalex.org/I4210150902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033956905","display_name":"Yasushi Goto","orcid":"https://orcid.org/0000-0002-7437-5054","observed_orcids":["https://orcid.org/0000-0002-7437-5054"]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasushi Goto","raw_affiliation_strings":["6National Cancer Centre Hospital, Tokyo, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6National Cancer Centre Hospital, Tokyo, Japan;","institution_ids":["https://openalex.org/I4210087348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007652011","display_name":"\u00d6rvar Gunnarsson","orcid":"https://orcid.org/0000-0001-8581-2769","observed_orcids":["https://orcid.org/0000-0001-8581-2769"]},"institutions":[{"id":"https://openalex.org/I4210106610","display_name":"National University Hospital of Iceland","ror":"https://ror.org/011k7k191","country_code":"IS","type":"funder","lineage":["https://openalex.org/I4210106610"]}],"countries":["IS"],"is_corresponding":false,"raw_author_name":"Orvar Gunnarsson","raw_affiliation_strings":["7Landspitali University Hospital, Reykjavik, Iceland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Landspitali University Hospital, Reykjavik, Iceland;","institution_ids":["https://openalex.org/I4210106610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028935333","display_name":"Tobias Raphael Overbeck","orcid":"https://orcid.org/0000-0002-2579-0171","observed_orcids":["https://orcid.org/0000-0002-2579-0171"]},"institutions":[{"id":"https://openalex.org/I4210116730","display_name":"Universit\u00e4tsmedizin G\u00f6ttingen","ror":"https://ror.org/021ft0n22","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210116730"]},{"id":"https://openalex.org/I74656192","display_name":"University of G\u00f6ttingen","ror":"https://ror.org/01y9bpm73","country_code":"DE","type":"education","lineage":["https://openalex.org/I74656192"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tobias Overbeck","raw_affiliation_strings":["8University Hospital G\u00f6ttingen - University Medical Centre G\u00f6ttingen, Groningen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8University Hospital G\u00f6ttingen - University Medical Centre G\u00f6ttingen, Groningen, Germany;","institution_ids":["https://openalex.org/I4210116730","https://openalex.org/I74656192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087391532","display_name":"Noem\u0131\u0301 Reguart","orcid":"https://orcid.org/0000-0001-8190-499X","observed_orcids":["https://orcid.org/0000-0001-8190-499X"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Noemi Reguart","raw_affiliation_strings":["9Hospital Clinic i Provincial de Barcelona, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Hospital Clinic i Provincial de Barcelona, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210115097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034434819","display_name":"Martin Wermke","orcid":"https://orcid.org/0000-0002-4844-4087","observed_orcids":["https://orcid.org/0000-0002-4844-4087"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Wermke","raw_affiliation_strings":["10Uniklinikum Dresden, Dresden, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Uniklinikum Dresden, Dresden, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046957099","display_name":"G. Castro","orcid":"https://orcid.org/0000-0001-8765-3044","observed_orcids":["https://orcid.org/0000-0001-8765-3044"]},"institutions":[{"id":"https://openalex.org/I4210088998","display_name":"Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo","ror":"https://ror.org/005vqqr19","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210088998"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gilberto Castro Castro","raw_affiliation_strings":["11Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo, S\u00e3o Paulo, Brazil;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo, S\u00e3o Paulo, Brazil;","institution_ids":["https://openalex.org/I4210088998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090324173","display_name":"Enriqueta Felip","orcid":"https://orcid.org/0000-0002-7620-0098","observed_orcids":["https://orcid.org/0000-0002-7620-0098"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Enriqueta Felip","raw_affiliation_strings":["12Vall d'Hebron Institute of Oncology, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Vall d'Hebron Institute of Oncology, Barcelona, Spain;","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018478201","display_name":"Alastair Greystoke","orcid":"https://orcid.org/0000-0001-9168-0387","observed_orcids":["https://orcid.org/0000-0001-9168-0387"]},"institutions":[{"id":"https://openalex.org/I4210124950","display_name":"Newcastle upon Tyne Hospital","ror":"https://ror.org/02w91w637","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210109172","https://openalex.org/I4210124950"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alastair Greystoke","raw_affiliation_strings":["13Newcastle upon Tyne Hospitals, High Heaton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Newcastle upon Tyne Hospitals, High Heaton, United Kingdom;","institution_ids":["https://openalex.org/I4210124950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045959942","display_name":"Benjamin Solomon","orcid":"https://orcid.org/0000-0003-3059-5730","observed_orcids":["https://orcid.org/0000-0003-3059-5730"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Benjamin J. Solomon","raw_affiliation_strings":["14Peter MacCallum Cancer Centre, Melbourne, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Peter MacCallum Cancer Centre, Melbourne, Australia;","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037790221","display_name":"St\u00e9phanie Deudon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Stephanie Deudon","raw_affiliation_strings":["15Novartis Pharma AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Novartis Pharma AG, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112488822","display_name":"Anne-Laure Louveau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092929","display_name":"Novartis (France)","ror":"https://ror.org/00geypp27","country_code":"FR","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210092929"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne-Laure Louveau","raw_affiliation_strings":["16Novartis Pharma SAS, Rueil-Malmaison, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Novartis Pharma SAS, Rueil-Malmaison, Paris, France;","institution_ids":["https://openalex.org/I4210092929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110708698","display_name":"Vanessa Q. Passos","orcid":"https://orcid.org/0000-0002-8127-3304","observed_orcids":["https://orcid.org/0000-0002-8127-3304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vanessa Passos","raw_affiliation_strings":["17Novartis Pharmaceuticals Corporation, East Hanover, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Novartis Pharmaceuticals Corporation, East Hanover, NJ;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063823247","display_name":"Daniel S.W. Tan","orcid":"https://orcid.org/0000-0002-6514-6786","observed_orcids":["https://orcid.org/0000-0002-6514-6786"]},"institutions":[{"id":"https://openalex.org/I4210137145","display_name":"National Cancer Centre Singapore","ror":"https://ror.org/03bqk3e80","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210137145"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Daniel SW Tan","raw_affiliation_strings":["18National Cancer Centre, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18National Cancer Centre, Singapore, Singapore","institution_ids":["https://openalex.org/I4210137145"]}]}],"institutions":[],"countries_distinct_count":13,"institutions_distinct_count":17,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"CT214","last_page":"CT214"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4462999999523163,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4462999999523163,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.33230000734329224,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.1615000069141388,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canakinumab","display_name":"canakinumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9039999842643738},{"id":"https://openalex.org/keywords/il-1beta-inhibition","display_name":"IL-1\u03b2 inhibition","score":0.8379999995231628},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6679999828338623},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.6079999804496765},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9359999895095825},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.8740000128746033},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9620000123977661},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.593999981880188},{"id":"https://openalex.org/keywords/safety-run-in","display_name":"safety run-in","score":0.6819999814033508},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.5830000042915344},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.4350000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7835959196090698},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.7429280281066895},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.7291967272758484},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6576337218284607},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.634775698184967},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5845590829849243},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5262371897697449},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4452096223831177},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.42652803659439087},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.40488722920417786},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37354904413223267},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.2952382564544678},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.26429325342178345}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-ct214","doi":"https://doi.org/10.1158/1538-7445.am2020-ct214","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-ct214","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8799999952316284}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4322183511","https://openalex.org/W2981688104","https://openalex.org/W2883512185","https://openalex.org/W2922729092","https://openalex.org/W2948776902","https://openalex.org/W2770587120","https://openalex.org/W3206685234","https://openalex.org/W2566596022","https://openalex.org/W2924952671","https://openalex.org/W3127521146"],"abstract_inverted_index":{"Abstract":[0],"Cytokine":[1],"interleukin-1\u03b2":[2],"(IL-1\u03b2)":[3],"has":[4,49],"multiple":[5],"pro-tumorogenic":[6],"effects":[7,36],"on":[8,342,491],"tumor":[9,14],"microenvironment,":[10],"thereby":[11,34],"promoting":[12],"carcinogenesis,":[13],"invasiveness,":[15],"and":[16,64,96,122,191,194,226,251,290,296,298,363,369,397,401,413,448,460,474,493,511,622],"immunosuppression.":[17],"CAN":[18,54,79,103,143,197,217,327,453,485,501],"is":[19,84,134,189,519],"a":[20,72,85],"selective":[21],"IL-1\u03b2":[22,51],"inhibitor":[23],"that":[24],"aims":[25],"to":[26,30,74,93,303,323,376,379,431,457],"target":[27],"tumor-promoting":[28],"inflammation":[29],"reduce":[31],"immune":[32],"suppression,":[33],"potentiating":[35],"of":[37,60,78,98,196,206,216,229,234,258,314,326,351,372,433,435,463,465,500,575,607,611],"immunotherapy":[38],"with":[39,53,57,69,108,330,484,584,599],"PD-1":[40],"inhibitors":[41],"such":[42],"as":[43,502,592],"PEM.":[44],"Ph":[45],"3":[46,90,212,319,364,411,442,471,573],"CANTOS":[47],"study":[48,126,304,315,437,466,574],"shown":[50],"inhibition":[52],"was":[55,127,265,283,336,482,508],"associated":[56],"reduced":[58],"incidence":[59],"lung":[61],"cancer":[62],"(LC)":[63],"LC":[65],"mortality":[66],"in":[67,80,104,245,249,254,288,294,328,355,361,367,441,470,581,596],"pts":[68,107,141,244,248,253,272,287,358,360,365,407,444,473],"atherosclerosis,":[70],"providing":[71],"rationale":[73],"investigate":[75],"therapeutic":[76],"role":[77],"LC.":[81],"CANOPY-1":[82],"(NCT03631199)":[83],"PBO-controlled,":[86],"double-blind,":[87],"randomized,":[88],"ph":[89,211],"trial":[91],"designed":[92],"evaluate":[94],"efficacy":[95,193],"safety":[97,137,195,207],"PEM":[99,149,333,487],"+":[100,148,154,169,176,185,334,486,488],"Ctx":[101,156,335],"\u00b1":[102],"tx":[105,281,316],"naive":[106],"stage":[109,119],"IIIB/IIIC":[110],"(not":[111],"eligible":[112],"for":[113,280,515,615],"definitive":[114],"chemo-radiation":[115],"curative":[116],"tx)":[117],"or":[118,182,578,601],"IV":[120],"squamous":[121,181],"nonsquamous":[123],"NSCLC.":[124],"The":[125],"divided":[128],"into":[129],"2":[130,188],"parts:":[131],"part":[132,139,518],"1":[133,291,299,306,414,480],"open":[135],"labelled,":[136],"run-in":[138,208,568],"where":[140],"received":[142],"200":[144,150,337,503],"mg":[145,151,338,504],"s.c":[146],"Q3W":[147,153,340,506],"i.v":[152],"platinum-based":[155,588],"(as":[157],"induction":[158],"during":[159,310],"first":[160,311],"4":[161,418],"cycles":[162],"only);":[163],"Cohort":[164,171,178],"A":[165,289,362],"(A,":[166],"non-squamous),":[167,174,183],"carboplatin":[168,184],"pemetrexed;":[170,177],"B":[172,295,368],"(B,":[173],"cisplatin":[175],"C":[179,255],"(C,":[180],"paclitaxel.":[186],"Part":[187],"randomized":[190,517],"evaluates":[192],"comb":[198,202,329,507],"regimen":[199,214],"vs":[200],"PBO":[201],"regimen.":[203],"Primary":[204],"objective":[205],"part:":[209],"recommended":[210],"dose":[213,332,458,461],"(RP3R)":[215],"comb.":[218],"Secondary":[219],"objectives:":[220],"ORR,":[221],"DCR,":[222],"DOR,":[223],"safety,":[224],"PK,":[225],"immunogenicity.":[227],"As":[228],"14":[230,406],"May":[231],"2019":[232],"(follow-up":[233],"\u226542":[235],"days":[236,313],"from":[237,570],"C1D1":[238],"unless":[239],"pt":[240,292,300,307,415],"discontinued":[241],"earlier),":[242],"10":[243],"A,":[246],"11":[247],"B,":[250],"9":[252],"were":[256,261,274,353,374,391,427,439,452,468],"treated,":[257],"which":[259,373],"73%":[260],"male,":[262],"median":[263],"age":[264],"63":[266],"yrs.":[267],"In":[268],"total,":[269],"24/30":[270],"(80%)":[271],"enrolled":[273],"still":[275],"receiving":[276],"tx;":[277],"primary":[278],"reason":[279],"discontinuation":[282,432],"progressive":[284],"disease":[285],"(3":[286],"each":[293,366],"C)":[297],"died":[301],"due":[302],"indication.":[305],"reported":[308,354,440,469,483],"DLT":[309,481],"42":[312],"(C:":[317],"grade":[318,410,417],"hepatitis,":[320],"not":[321],"related":[322,378],"CAN).":[324],"RP3R":[325,499],"standard":[331],"SC":[339,505],"based":[341],"Bayesian":[343],"logistic":[344],"regression":[345],"model":[346],"(BLRM).":[347],"Serious":[348],"AEs":[349,383,412,426,429,455],"regardless":[350],"causality":[352],"8":[356],"(27%)":[357],"(2":[359],"C),":[370],"none":[371,451],"considered":[375,509],"be":[377],"CAN.":[380],"Most":[381],"common":[382],"(\u226520%,":[384],"any":[385],"grade)":[386],"across":[387],"all":[388,494],"cohorts":[389],"(n=30)":[390],"nausea":[392],"(37%),":[393],"vomiting":[394],"(30%),":[395],"constipation":[396],"fatigue":[398],"(each":[399],"23%),":[400],"neutrophil":[402],"count":[403],"decrease":[404],"(20%).":[405],"(47%)":[408],"experienced":[409,416],"AE":[419],"(cardiac":[420],"tamponade":[421],"[unrelated]).":[422],"No":[423],"fatal":[424],"serious":[425],"reported.":[428],"leading":[430,456],"one":[434,464],"the":[436,498,516,608,612],"drugs":[438,467],"(10%)":[443,472],"(hepatitis,":[445],"peripheral":[446],"neuropathy,":[447],"polyneuropathy)":[449],"but":[450],"related.":[454],"reduction":[459],"interruption":[462],"5":[475],"(17%)":[476],"pts,":[477],"respectively.":[478],"Only":[479],"Ctx.":[489],"Based":[490],"BLRM":[492],"relevant":[495],"clinical":[496],"data,":[497],"safe":[510],"well":[512],"tolerated.":[513],"Enrollment":[514],"completed.":[520],"Citation":[521],"Format:":[522],"Bruce":[523],"E.":[524],"Johnson,":[525],"Tae":[526],"Min":[527],"Kim,":[528],"T.":[529],"Jeroen":[530],"N.":[531],"Hiltermann,":[532],"Fabrice":[533],"Barlesi,":[534],"Christian":[535],"Grohe,":[536],"Yasushi":[537],"Goto,":[538],"Orvar":[539],"Gunnarsson,":[540],"Tobias":[541],"Overbeck,":[542],"Noemi":[543],"Reguart,":[544],"Martin":[545],"Wermke,":[546],"Gilberto":[547],"Castro":[548],"Castro,":[549],"Enriqueta":[550],"Felip,":[551],"Alastair":[552],"Greystoke,":[553],"Benjamin":[554],"J.":[555],"Solomon,":[556],"Stephanie":[557],"Deudon,":[558],"Anne-Laure":[559],"Louveau,":[560],"Vanessa":[561],"Passos,":[562],"Daniel":[563],"SW":[564],"Tan.":[565],"CANOPY-1:":[566],"Safety":[567],"results":[569],"phase":[571],"(ph)":[572],"canakinumab":[576],"(CAN)":[577],"placebo":[579],"(PBO)":[580],"combination":[582],"(comb)":[583],"pembrolizumab":[585],"(PEM)":[586],"plus":[587],"doublet":[589],"chemotherapy":[590],"(Ctx)":[591],"1st":[593],"line":[594],"therapy":[595],"patients":[597],"(pts)":[598],"advanced":[600],"metastatic":[602],"NSCLC":[603],"[abstract].":[604],"In:":[605],"Proceedings":[606],"Annual":[609],"Meeting":[610],"American":[613],"Association":[614],"Cancer":[616,628],"Research":[617],"2020;":[618],"2020":[619],"Apr":[620],"27-28":[621],"Jun":[623],"22-24.":[624],"Philadelphia":[625],"(PA):":[626],"AACR;":[627],"Res":[629],"2020;80(16":[630],"Suppl):Abstract":[631],"nr":[632],"CT214.":[633]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}